Mapping Aldehyde Dehydrogenase 1A1 Activity using an [18F]Substrate‐Based Approach

Abstract

Abstract Aldehyde dehydrogenases (ALDHs) catalyze the oxidation of aldehydes to carboxylic acids. Elevated ALDH expression in human cancers is linked to metastases and poor overall survival. Despite ALDH being a poor prognostic factor, the non‐invasive assessment of ALDH activity in vivo has not been possible due to a lack of sensitive and translational imaging agents. Presented in this report are the synthesis and biological evaluation of ALDH1A1‐selective chemical probes composed of an aromatic aldehyde derived from N,N‐diethylamino benzaldehyde (DEAB) linked to a fluorinated pyridine ring either via an amide or amine linkage. Of the focused library of compounds evaluated, N‐ethyl‐6‐(fluoro)‐N‐(4‐formylbenzyl)nicotinamide 4\u2009b was found to have excellent affinity and isozyme selectivity for ALDH1A1 in vitro. Following 18F‐fluorination, [18F]4\u2009b was taken up by colorectal tumor cells and trapped through the conversion to its 18F‐labeled carboxylate product under the action of ALDH. In vivo positron emission tomography revealed high uptake of [18F]4\u2009b in the lungs and liver, with radioactivity cleared through the urinary tract. Oxidation of [18F]4\u2009b, however, was observed in vivo, which may limit the tissue penetration of this first‐in‐class radiotracer.